谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase 2 Trial Of The Alternating Therapy With Osimertinib And Afatinib For Treatment-Naive Patients With Egfr-Mutated Advanced Non-Small Cell Lung Cancer (Wjog10818l/Alt Trial)

H. Hayashi,K. Yonesaka,S. Sugawara,Y. Sato,K. Azuma,S. Sakata,M. Tachihara,S. Ikeda,T. Yokoyama,O. Hataji,Y. Yano,K. Hirano,H. Daga, H. Okada,K. Sakai,Y. Chiba,K. Nishio,N. Yamamoto,K. Nakagawa

JOURNAL OF THORACIC ONCOLOGY（2021）

引用 0|浏览14
暂无评分
关键词
EGFR mutation, Afatinib, osimertinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要